APA (7th ed.) Citation

Höfner, T., Vallet, S., Hadaschik, B., Pahernik, S., Duensing, S., Hohenfellner, M., . . . Grüllich, C. (2015). Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: Efficacy and predictive parameters in a large single center cohort. World journal of urology, 33(6), . https://doi.org/10.1007/s00345-014-1375-5

Chicago Style (17th ed.) Citation

Höfner, Thomas, Sonia Vallet, Boris Hadaschik, Sascha Pahernik, Stefan Duensing, Markus Hohenfellner, Dirk Jäger, and Carsten Grüllich. "Docetaxel Followed by Abiraterone in Metastatic Castration-resistant Prostate Cancer: Efficacy and Predictive Parameters in a Large Single Center Cohort." World Journal of Urology 33, no. 6 (2015). https://doi.org/10.1007/s00345-014-1375-5.

MLA (9th ed.) Citation

Höfner, Thomas, et al. "Docetaxel Followed by Abiraterone in Metastatic Castration-resistant Prostate Cancer: Efficacy and Predictive Parameters in a Large Single Center Cohort." World Journal of Urology, vol. 33, no. 6, 2015, https://doi.org/10.1007/s00345-014-1375-5.